Flag of the European Union EU Clinical Trials Register Help

Clinical trials for potasio

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   43845   clinical trials with a EudraCT protocol, of which   7282   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    46 result(s) found for: potasio. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2008-002191-98 Sponsor Protocol Number: PREVARENAL-08 Start Date*: 2008-11-27
    Sponsor Name:Servicio de Nefrologia-Hospital Universitario Vall d'Hebron
    Full Title: "Efecto del ARA-II Olmesartan sobre el metabolismo del potasio en pacientes con insuficiencia renal crónica"
    Medical condition: Microalbuminúria, hipertensión arterial y renoprotección en la insuficiencia renal crónica.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-014313-27 Sponsor Protocol Number: RAL-IC Start Date*: 2009-11-11
    Sponsor Name:Fundació Lluita contra la SIDA
    Full Title: ESTUDIO PILOTO PARA COMPARAR LOS PARÁMETROS FARMACOCINÉTICOS EN PLASMA E INTRACELULARES DE RALTEGRAVIR ADMINISTRADO UNA VEZ AL DÍA EN PACIENTES ADULTOS INFECTADOS POR EL VIH.
    Medical condition: Infección VIH-1
    Disease: Version SOC Term Classification Code Term Level
    9 10008919 Chronic HIV infection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-004460-66 Sponsor Protocol Number: KARAASS-1 Start Date*: 2014-04-01
    Sponsor Name:Jørgen Jeppesen
    Full Title: Oral potassium supplementation in healthy men - interactions with the renin-angiotensin-aldosterone system and the sympathetic nervous system
    Medical condition: Blood pressure regulation and hypertension
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004866 10008393 Change in blood pressure LLT
    16.1 100000004865 10053967 Potassium supplementation LLT
    Population Age: Adults Gender: Male
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-014480-39 Sponsor Protocol Number: LLC-RAET-2009-1 Start Date*: 2010-02-18
    Sponsor Name:Luis Fernando López Cortés
    Full Title: Concentraciones plasmáticas e intracelulares de Raltegravir y Etravirina administrados una vez al día (800 mg y 400 mg, respectivamente) comparado con su dosificación estándard (400 mg y 200 mg/12 ...
    Medical condition: Pacientes con infección por el VIH en tratamiento con raltegravir o etravirina. HIV-Patients on treatment with raltegravir or etravirine
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-005473-35 Sponsor Protocol Number: DISCOR-RAL Start Date*: 2008-11-12
    Sponsor Name:Fundació Lluita contra la SIDA
    Full Title: PILOT STUDY TO ASSESS THE ROLE OF IMMUNE ACTIVATION AND APOPTOSIS AS A MARKER FOR TREATMENT INTENSIFICATION WITH RALTEGRAVIR IN HIV-INFECTED PATIENTS ON ANTIRETROVIRAL THERAPY WITH LONG-TERM VIRAL ...
    Medical condition: Infección VIH-1
    Disease: Version SOC Term Classification Code Term Level
    9 10008919 Chronic HIV infection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-005663-34 Sponsor Protocol Number: EC20081 Start Date*: 2009-06-26
    Sponsor Name:Joseba Andoni Santamaría Zuazua
    Full Title: Ensayo clínico sobre la eficacia de una pauta con amoxicilina/clavulánico 2000/125 mg (GE) cada doce horas, frente a placebo(GC) en la prevención de la infeccion postoperatoria tras la exodoncia de...
    Medical condition: prevención de la infección postoperatorioa tras la exodoncia de terceros molares totalmente incluidos recubiertos por hueso mandibular
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-019135-35 Sponsor Protocol Number: PillCam2010 Start Date*: 2010-06-11
    Sponsor Name:Dr. Enrique
    Full Title: Evaluación de la limpieza intestinal en un día para la colonoscopia con cápsula colónica: estudio piloto
    Medical condition: Detección de Cancer colorrectal
    Disease: Version SOC Term Classification Code Term Level
    11 10010040 Neoplasias colorrectales NCOC HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-021360-15 Sponsor Protocol Number: IG0905 Start Date*: 2010-12-20
    Sponsor Name:Instituto Grifols S.A.
    Full Title: "EFECTOS DEL RECAMBIO PLASMÁTICO SOBRE LA CAPACIDAD FUNCIONAL DE LA ALBÚMINA SÉRICA, LA DISFUNCIÓN CIRCULATORIA, LA FUNCION RENAL Y CEREBRAL EN PACIENTES CIRRÓTICOS CON “ACUTE-ON-CHRONIC LIVER FAIL...
    Medical condition: Pacientes cirróticos con "Acute on chronic liver failure"
    Disease: Version SOC Term Classification Code Term Level
    13 10008954 Enfermedad hepática crónica y cirrosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2010-022901-16 Sponsor Protocol Number: TRAMA Start Date*: 2011-07-28
    Sponsor Name:Gemma Rialp
    Full Title: Estudio multicéntrico sobre el efecto del tratamiento de la alcalosis metabólica con acetazolamida en la duración de la ventilación mecánica.
    Medical condition: Enfermedad pulmonar obstructiva crónica y síndrome de obesidad ventilación
    Disease: Version SOC Term Classification Code Term Level
    13 10009725 EPOC LLT
    13 10064205 Síndrome de obesidad-hipoventilación LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2004-001270-77 Sponsor Protocol Number: TRASVAL Start Date*: 2005-03-01
    Sponsor Name:Equipo de doctores: Dr. Amado Andrés y Dr. Manuel Praga
    Full Title: Estudio piloto para evaluar la eficacia y seguridad de Valsartán para el control de la progresión de la insuficiencia renal y la morbimortalidad cardiovascular en pacientes con trasplante renal fun...
    Medical condition: Pacientes varones y mujeres de 18 a 70 años con trasplantes renales funcionantes de más de 1 año de evolución y una insuficiencia renal leve o moderada (creatinina sérica > 1,3 mg/dl en mujeres y >...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-001192-29 Sponsor Protocol Number: cv-08/025 Start Date*: 2008-06-03
    Sponsor Name:Fundación Investigación y Desarrollo en el Area Cardiovascular
    Full Title: “Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensi...
    Medical condition: Disfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada. Low-moderate ventricular dysfunction in post-acute coronary sy...
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-007044-10 Sponsor Protocol Number: EC07/90842 Start Date*: 2008-03-04
    Sponsor Name:JOSÉ ANTONIO SERRANO TRENAS
    Full Title: UTILIDAD DEL HIERO INTRAVENOSO EN EL PACIENTE ANCIANO CON FRACTURA DE CADERA
    Medical condition: SE INVESTIGA LA POSIBILIDAD DE REDUCCIÓN DE LAS NECESIDADES TRANSFUSIONALES DE LOS PACIENTES ANCIANOS INTERVENIDOS DE FRACTURA DE CADERA MEDIANTE SU TRATAMIENTO CON HIERRO INTRAVENOSO.
    Disease:
    Population Age: Elderly Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-012963-33 Sponsor Protocol Number: CORTEEC Start Date*: 2010-10-04
    Sponsor Name:ALFREDO TAGARRO GARCIA
    Full Title: ENSAYO CLINICO FASE II CORTICOIDES PARA EL EMPIEMA Y EL DERRAME PLEURAL PARANEUMÓNICO EN NIÑOS MULTICENTRIC, PHASE II, CLINICAL TRIAL CORTICOIDS FOR EMPYEMA AND PLEURAL EFFUSION IN CHILDREN
    Medical condition: DERRAME PLEURAL PARANEUMONICO (PARAPNEUMONIC PLEURAL EFFUSSION)
    Disease: Version SOC Term Classification Code Term Level
    11 10032736 Otras formas especificadas de derrame pleural, excepto el tuberculoso LLT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: ES (Restarted)
    Trial results: (No results available)
    EudraCT Number: 2018-005030-38 Sponsor Protocol Number: PAT-CR-302 Start Date*: 2019-08-10
    Sponsor Name:Vifor Pharma, Inc.
    Full Title: A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone Syst...
    Medical condition: Management of hyperkalemia due to renin-angiotension-aldosterone system medications in patients treated for heart failure.
    Disease: Version SOC Term Classification Code Term Level
    21.0 10022891 - Investigations 10005725 Blood potassium increased PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: PL (Completed) CZ (Completed) NL (Completed) ES (Ongoing) HU (Completed) DE (Completed) BG (Completed) GB (GB - no longer in EU/EEA) BE (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-014406-34 Sponsor Protocol Number: ORVACS-010 Start Date*: 2010-05-28
    Sponsor Name:ORVACS
    Full Title: International, multicenter, randomized, non-comparative controlled study of therapeutic intensification plus immunomodulation in HIV patients with long-term viral suppression
    Medical condition: HIV-1 Infection
    Disease: Version SOC Term Classification Code Term Level
    12.0 10008919 Chronic HIV infection LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Ongoing) GB (Completed) ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-005468-28 Sponsor Protocol Number: CQAB149B2340 Start Date*: 2008-01-18
    Sponsor Name:Novartis Pharma Services AG
    Full Title: A Phase III, randomized, double-blind, placebo controlled, multicenter, 3-period, 14 day crossover study to determine the 24-h lung function profile of indacaterol (300 μg o.d.) in patients with mo...
    Medical condition: moderate to severe chronic obstructive pulmonary disease (COPD).
    Disease: Version SOC Term Classification Code Term Level
    9.1 10010952 COPD LLT
    Population Age: Gender: Male, Female
    Trial protocol: BE (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-013093-41 Sponsor Protocol Number: AC220-002 Start Date*: 2010-02-05
    Sponsor Name:Ambit Biosciences Corporation
    Full Title: A PHASE 2 OPEN-LABEL, AC220 MONOTHERAPY EFFICACY (ACE) STUDY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WITH FLT3-ITD ACTIVATING MUTATIONS
    Medical condition: Acute Myeloid Leukemia
    Disease: Version SOC Term Classification Code Term Level
    12.0 10000886 Acute myeloid leukemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) DE (Completed) ES (Completed) NL (Completed) PL (Completed) IT (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-017950-11 Sponsor Protocol Number: ING113086 Start Date*: 2010-11-10
    Sponsor Name:ViiV Healthcare S.L
    Full Title: Estudio fase III, aleatorizado, doble ciego, para evaluar la eficacia y la seguridad de 50 mg de GSK1349572 una vez al día, frente a 400mg de raltegravir dos veces al día, ambos administrados con u...
    Medical condition: Pacientes adultos infectados por el VIH-1 que no han recibido tratamiento antirretroviral previo
    Disease: Version SOC Term Classification Code Term Level
    12.1 10008922 Chronic infection with HIV LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) DE (Completed) FR (Completed) GB (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2009-012616-40 Sponsor Protocol Number: CAMN107A2405 Start Date*: 2009-08-11
    Sponsor Name:Novartis Pharma Services AG
    Full Title: An Open Label, Randomized Study of Nilotinib vs. Standard Imatinib (400/600 mg QD) Comparing the Kinetics of Complete Molecular Response for CML-CP Patients with Evidence of Persistent Leukemia by ...
    Medical condition: Chronic Myelogenous Leukemia in Chronic Phase
    Disease: Version SOC Term Classification Code Term Level
    9.1 10009012 Chronic myelogenous leukemia LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed) GB (Prematurely Ended) ES (Completed)
    Trial results: View results
    EudraCT Number: 2009-010208-27 Sponsor Protocol Number: CLCZ696B2214 Start Date*: 2009-06-29
    Sponsor Name:Novartis Farmacéutica S.A
    Full Title: Estudio aleatorizado, doble ciego, multicéntrico, de grupos paralelos, controlado con tratamiento activo de doce semanas de seguimiento para evaluar la eficacia, seguridad y tolerabilidad de LCZ696...
    Medical condition: Insuficiencia Cardiaca crónica
    Disease: Version SOC Term Classification Code Term Level
    9.1 10008908 Chronic heart failure LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed) NL (Completed) IT (Completed) PL (Completed) DE (Completed)
    Trial results: View results
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Fri Apr 19 06:37:19 CEST 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA